Respiratory depression is a common side effect when opioids are used to immobilize wildlife. Serotonergic ligands have the potential to reverse opioid-induced respiratory depression. We examined whether any of three serotonergic ligands could reverse this depression in etorphine-immobilized (0.07 mg/kg) impala (Aepyceros melampus). The study took place in September–December 2007. Impala received intravenous injections of metoclopramide (10 mg/ kg, n=6), buspirone (0.05 mg/kg, n=8), pimozide (1 mg/kg, n=8), doxapram (1 mg/kg, n=6), and control solutions on separate occasions. During the immobilization, partial pressures of oxygen (PaO2, mmHg) and carbon dioxide (PaCO2, mmHg), respiratory rate (breaths/min), ventilation (l/ min), peripheral O2 saturation (%), tidal volume (l), and respiratory exchange ratio were measured before and after injection of the experimental drugs. Etorphine immobilization caused respiratory depression and hypoxia (mean±SD, PaCO2=51±2 mmHg, PaO2=40±3 mmHg). Metoclopra-mide and buspirone, but not pimozide, attenuated the hypoxic effects of etorphine; 3 min after injection, metoclopramide increased the PaO2 by 7.=66.3 mmHg and buspirone by 666.6 mmHg (F=3.9, P=0.02). These effects were similar to those of doxapram (8±7 mmHg, F=3.9; P>0.05). Neither metoclopramide nor buspirone significantly increased ventilation, but they increased PaO2 by significantly improving the alveolar-arterial oxygen partial pressure gradient (A-a gradient, F=1.4, P<0.05), indicating improved oxygen diffusion. Metoclopramide and buspirone transiently improved blood oxygenation of opioid-immobilized impala, probably by improving ventilation-perfusion ratios, without reversing catatonic immobilization.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 46 • No. 2